Company Filing History:
Years Active: 2021
Title: Steven Devine - Innovator in Cancer Immunotherapy
Introduction
Steven Devine is a prominent inventor based in Columbus, OH (US). He has made significant contributions to the field of cancer treatment through his innovative work in immunotherapy. His research focuses on developing new methods to combat cancer, particularly through the use of engineered CAR cells.
Latest Patents
Steven holds a patent for "FLT3 directed CAR cells for immunotherapy." This patent describes CAR cells that target FLT3 relevant antigens, presenting a novel approach to cancer treatment. The proposed FLT3 CAR cells are considered safe and effective for patients, with the potential to treat various human tumors and cancers. He has 1 patent to his name.
Career Highlights
Steven is currently associated with Cytoimmune Therapeutics, Inc., where he continues to advance his research in cancer immunotherapy. His work is pivotal in the ongoing efforts to improve treatment options for cancer patients.
Collaborations
Steven collaborates with notable colleagues, including Jianhua Yu and Michael A. Caligiuri. Their combined expertise enhances the research and development of innovative cancer therapies.
Conclusion
Steven Devine's contributions to cancer immunotherapy through his patented innovations highlight his role as a key figure in the fight against cancer. His work continues to inspire advancements in medical science and offers hope for improved treatment options for patients.